Correlation Between Kezar Life and Iteos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Iteos Therapeutics, you can compare the effects of market volatilities on Kezar Life and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Iteos Therapeutics.

Diversification Opportunities for Kezar Life and Iteos Therapeutics

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kezar and Iteos is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Kezar Life i.e., Kezar Life and Iteos Therapeutics go up and down completely randomly.

Pair Corralation between Kezar Life and Iteos Therapeutics

Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Iteos Therapeutics. In addition to that, Kezar Life is 1.24 times more volatile than Iteos Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Iteos Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest  860.00  in Iteos Therapeutics on August 25, 2024 and sell it today you would lose (28.00) from holding Iteos Therapeutics or give up 3.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Kezar Life Sciences  vs.  Iteos Therapeutics

 Performance 
       Timeline  
Kezar Life Sciences 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.
Iteos Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iteos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Kezar Life and Iteos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kezar Life and Iteos Therapeutics

The main advantage of trading using opposite Kezar Life and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.
The idea behind Kezar Life Sciences and Iteos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance